This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Stefan Dengl and His Patent Work.
Introduction
Stefan Dengl is an inventor based in Basel, Switzerland. His patent work includes an invention concerning an antibody that binds to VEGF and IL-1β.
Latest Patents
Dengl is associated with 1 patent: “Antibody That Binds to VEGF and IL-1β and Methods of Use.” The patent describes an antibody targeting both VEGF and IL-1β and methods for using it.
Career Highlights
Dengl is associated with Hoffmann-La Roche Inc., a company active in pharmaceutical research and development. His listed patent reflects work related to antibody-based approaches.
Collaborations
Dengl’s listed coworkers include Roland Beckmann and Joerg Benz.
Conclusion
Stefan Dengl’s patent record connects his work in Basel with Hoffmann-La Roche Inc. and research into antibodies that bind to VEGF and IL-1β.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile